JPRN-UMIN000000488
Completed
Phase 2
A phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis - Hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis
Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital0 sites25 target enrollmentSeptember 12, 2006
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital
- Enrollment
- 25
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Prior chemotherapy with cisplatin for hepatocellular carcinoma 2\) Prior radiotherapy, transcatheter arterial chemoembolization, and hepatic arterial chemotherapy for portal vein tumor thrombosis of hepatocellular carcinoma 3\) Refractory pleural effusion or ascites 4\) Distant metastases 5\) Allergic reaction to iodine contrast material 6\) Severe renal disease 7\) Severe heart disease 8\) Active infection excluding hepatitis B or C viral infection 9\) Active concomitant malignancy 10\) Severe mental disorder 11\) Severe allergic reaction to drug 12\) Pregnant and lactating females; females of childbearing age unless using effective contraception
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
A phase I,II trial of hepatic arterial infusion chemotherapy with cisplatin and 5-fluorouracil for unresectable advanced hepatocellular carcinomahepatocellular carcinomaJPRN-UMIN000013734Sapporo Medical University School of Medicine28
Completed
Phase 1
A phase 1 trial of hepatic arterial infusion chemotherapy with high dose cisplatin and 5-fluorouracil for unresectable advanced and recurrent hepatocellular carcinomaJPRN-UMIN000015101Keio University, School of medicine, Department of Surgery18
Completed
Not Applicable
Clinical trial of hepatic arterial infusion chemotherapy with multidrug resistance-associated protein 3-derived peptide for hepatocellular carcinomaHepatocellular carcinoma (HCC)JPRN-UMIN000005678Department of Gastroenterology, Kanazawa University Hospital12
Completed
Phase 1
Phase I study of hepatic arterial infusion chemotherapy with gemcitabine and 5FU for postoperative liver metastases from pancreatic cancer.Postoperative liver metastases from pancreatic cancerJPRN-UMIN000011059Department of Gastroenterologic Surgery, Kanazawa University12
Completed
Not Applicable
Pilot study of hepatic arterial infusion chemotherapy followed by sorafenib for advanced hepatocellular carcinomaadvanced hepatocellular carcinomaJPRN-UMIN000009094Department of Gastroenterology and Metabolism,Hiroshima University Hospital55